<SEC-DOCUMENT>0001193125-21-005471-index.html : 20210111 <SEC-HEADER>0001193125-21-005471.hdr.sgml : 20210111 <ACCEPTANCE-DATETIME>20210108215959 ACCESSION NUMBER: 0001193125-21-005471 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20210111 DATE AS OF CHANGE: 20210108 GROUP MEMBERS: CHART WESTCOTT GROUP MEMBERS: IKARIAN HEALTHCARE FUND GP, L.P. GROUP MEMBERS: IKARIAN HEALTHCARE MASTER FUND, L.P. GROUP MEMBERS: NEIL SHAHRESTANI SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-80136 FILM NUMBER: 21518944 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Ikarian Capital, LLC CENTRAL INDEX KEY: 0001778253 IRS NUMBER: 473466768 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 100 CRESCENT COURT STREET 2: SUITE 1620 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 214-364-2883 MAIL ADDRESS: STREET 1: 100 CRESCENT COURT STREET 2: SUITE 1620 CITY: DALLAS STATE: TX ZIP: 75201 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>d106257dsc13g.htm <DESCRIPTION>SC 13G <TEXT> Document 1 - file: d106257dsc13g.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>d106257dex991.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: d106257dex991.htm
</DOCUMENT> </SEC-DOCUMENT>